VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Femoral nerve blockade
Preclinical
Small molecule
H
Helsinki University Central Hospital
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Femoral Nerve Block
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Femoral Nerve Block
Preclinical
Completed
Clinical
Trials by Indication
[1]
Femoral Nerve Block
1 trial
Femoral Nerve Blockade in Endovenous Laser
Completed
·
H
Helsinki University Central Hospital
·
N/A
·
NCT03475641
·
80 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Femoral nerve blockade. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Femoral nerve blockade compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Femoral nerve blockade. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Helsinki University Central Hospital company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
H
Helsinki University Central Hospital
Related News